UBM Medica US recently announced that the leading online community for primary care clinicians, ConsultantLive, has launched a new resource for diabetes to help busy clinicians to stay up-to-date with the latest news in diabetes care.
UBM Medica US delivers strategic and integrated communications solutions to improve the effectiveness of healthcare through both information and education. The company provides clinical practical and business information for physicians and payers to ameliorate the quality of care services around the world, using online magazines and journals, communities, live and digital events, and other resources suitable for this purpose.
According to The Centers for Disease Control and Prevention, diabetes has reached an epidemic level in the United States: 9.3 percent of the nation’s population have the disease (about 21.9 million people). November is National Diabetes Month and efforts are being made to spread the word about how important it is to control the disease and its role in reducing heart disease risk. Diabetes is known as a slow killer, as it can cause a number of other serious and even fatal complications such as heart disease, retinal detachment, renal failure, neurological affectation, impaired healing, etc. Type 1 is a condition that occurs when the body is incapable of keeping the production of its own insulin as a result of an autoimmune response against the pancreas. Type 2 diabetes, the most common and preventive type, results of an improper nutrition and of an unhealthy lifestyle.
Some of the most recent research findings are being offered on the their website, including the following: Slower Eating Increases Satiety Reduces Hunger in Type 2 Diabetes Patients — eating slower increases feelings of fullness and can really decrease hunger among obese and overweight people with type 2 diabetes; Menopause in Women with Diabetes: Hormonal-glycemic Storm –– for type 1 or type 2 diabetic women, menopause is not just a simple extended biological and physiological phase; Metabolic Syndrome: What Does it Look Like? — Mrs. Bates, 65 years old, takes only atorvastatin 40 mg and is in good health but has new complaints; Why Not Prescribe a SGLT2 Inhibitor for This Patient? — evaluation of a 76-year-old African American woman with type 2 diabetes and chronic kidney disease in which sodium glucose cotransporter-2 inhibitors may not work.
These new resources are bound to help the diabetes patient population better code with their condition and access new, effective treatment for managing blood sugar and other symptoms related to diabetes.
